Skip to main content
. Author manuscript; available in PMC: 2021 Oct 13.
Published in final edited form as: Mol Psychiatry. 2020 Aug 17;26(7):3302–3314. doi: 10.1038/s41380-020-00867-4

Table 1.

Study characteristics for all studies examining prospective associations of inflammatory biomarkers and depression included in systematic review.

Author Year Country Analytic Sample Baseline Age % Female % White Follow-up (Years)a In Meta-analysis? Depression assessed via interview? Biomarkers Assessed (Method) CRP>10b? Covariates? Exclusion Criteriac Quality
Khandaker et al. 2014 UK 4415 9 48.0 98 8.8 Yes No Blood No a , b, c, d, e, f, s d 7
Adriaensen et al. 2014 Belgium 303 84.3 62.7 nr 1.7 No No Blood No a, b, e, f, n, o, s a 5
Deverts et al. 2010 USA 2544 40.2 55.0 58.2 5.0 Yes No Blood Yes a, b, c, d, e, f, g, h, i, j, k, l, m, n, o, s d 6
Elovainio et al. 2006 Finland 1201 22.5 59.4 nr 9.0 Yes No Blood No a, b, d, e, h, i, j, k, l, s a 5
Simanek et al. 2014 USA 263 54 57.4 13.7 1.0 Yes No Blood No h, i, o, p c 5
Au et al. 2015 UK 3397 64.6 56 99 4.0 Yes No Blood No a, b, d, e, f, h, j, k, l, n, o, s none 5
Copeland et al. 2012 USA 1334 14.2 49 89.7 1.0 Yes Yes Finger Yes a, b, c, d, e, f, g, h, i, o, s none 5
Brown et al. 2016 USA 3075 73.6 52 58.3 10.0 No No Blood No CRP a, b, e, n, o, q d 4
Hiles et al. 2015 Australia 1410 65.6 50 nr 4.5 Yes No Blood Yes a, b, e, f, h, i, j, n, s a, b, d 5
Milaneschi et al. 2009 Italy 550 75 56 nr 3.0 No No Blood No c 6
de Mello Franco et al. 2017 Brazil 1508 41.31 19 nr 2.2 No No Blood Yes a, b, e, h, j, n a, d 5
Das et al. 2017 USA 2216 67.11 51 80.1 5.0 Yes No Finger Yes* a, b, c, d, e, f, g, n, o none 6
Stewart et al. 2009 USA 263 61 52 86.7 6.3 Yes No Blood Yes a, b, c, d, e, f, g, h, i, j, k, l, m, n, s a, b 6
Kern et al. 2014 Sweden 86 72.5 100 nr 16.5 No Yes CSF No CRP a, e, h a 4
Zalli et al. 2016 Holland 656 73 60 nr 5.0 Yes No Blood No a, b, e, f, h, n, q b, d 6
Simanek et al. 2019 USA 771 69.4 55 nr 1.5 No No Blood2 No a, b, c, d, e, g, h, i, o b, c 6
Matthews et al. 2010 USA 1714 46.2 100 51 1.0 Yes No Blood Yes a, c, d, e, f, g, h, j, n, o, s a, b, d 6
Baune et al. 2012 Australia 722 78.8 55 nr 2.0 Yes No Blood No a, b, d, e, h, n, o, q, s a, c 5
Duivis et al. 2015 Holland 1166 11.1 54 nr 3.0 Yes No Blood No* a, b, d, e, h, j d 6
Jonker et al. 2017 Holland 1084 16.2 54 nr 2.7 Yes Yes Blood Yes , b, c, d, e, h, i, s c, d 6
Casaletto et al. 2018 USA 165 72.6 49 nr 1.9 Yes No Blood No* a, b, d, s c, d 4
Kim et al. 2018 Korea 610 72.8 59 nr 2.4 Yes Yes Blood No CRP , b, f, g, j, n, s c 5
Luciano et al. 2012 Scotland 456 69.5 50 nr 3.0 Yes No Blood No* a, b, e, j, o a 6
Luukinen et al. 2010 Finland 404 nr 61 nr 2.5 No No Blood Yes c, d 5
Matsushima et al. 2015 Japan 64 72.05 74 nr 3.0 Yes No Blood No b, c 3
Nelson et al. 2018 Australia 63 14.84 41 77.8 0.6 Yes No Saliva No a, b, e, h, q, s b, c 3
Niles et al. 2018 USA 13375 67.79 60 81.61 4.0 Yes No Finger Yes a, d, e, f, g, h, i, j, n, s d 5
Pasco et al. 2010 Australia 644 47 100 nr 10.0 No Yes Blood No a, e, h, j, n, o none 6
Tully et al. 2015 Australia 1167 54.13 0 nr 4.9 Yes No Blood No a, e, h, j, n a, b, c 5
Walss-Bass et al. 2018 USA 195 13.37 54 58 0.9 No No Blood No* , c, d 3
Oddy et al. 2018 Australia 843 14 51 88 3.0 Yes No Blood Yes a, c, d, e, h, i, j, s d 5
Jones et al. 2017 USA 7477 63.47 100 53.8 15.4 Yes No Blood No* a, c, d, e, f, g, h, i, j, o, s d 5
Chiang et al. 2019 USA 187 16.4 57 nr 2.0 Yes No Finger Yes a, b, d, e, h, i, n, o d 5
van den Biggelaar et al. 2007 Holland 267 85 63 nr 1.0 Yes No Blood No e, f, h, n, q, s b, c 6
Glaus et al. 2018 Switzerland 2580 43.94 61 96.39 5.8 No Yes Blood Yes a, b, c, d, e, h, j, n, o, s d 7
Caserta et al. 2011 USA 141 9.31 46 47 0.5 No No Blood No CRP a, b, d, e, s a 3
Mac Giollabhui et al. 2019 USA 288 16.34 51 41 1.2 Yes No Blood Yes e, f, g, q, s a, c, d 6
Forti et al. 2010 Italy 652 74.54 55 nr 3.9 Yes No Blood No a, b, d, e, n, o, q, s c 5
a

= If more than two follow-up points of unequal length were included in the study, the average was calculated for the purpose of meta-regression.

b

= Were CRP values greater than or equal to 10mg/L excluded. Where alternative cut-offs were used they are highlighted with “*” and marked “Yes” if they use a more conservative cut-off and “No” if they use a more liberal cut-off.

c

= Represents a selection of the most important and common exclusion criteria used across studies.

1

= Median age reported.

2

= 32.4% assessed via venipuncture.

nr = not reported; Finger = Blood drawn via finger prick; CSF = cerebrospinal fluid;

Covariates: a = age, b = sex, c = race, d = socio-economic status, e = index of body mass/body fat, f = baseline depression, g = baseline inflammatory biomarker, h = smoking status, i = alcohol use, j = physical activity, k = triglycerides, l = cholesterol, m = glucose, n = medical diagnosis, o = medication use, p = stress, q = cognitive functioning, r = other

Exclusion criteria (non-exhaustive list): a = medical diagnosis, b = medication use, c = psychiatric diagnosis, d = acute infection.